Thursday, December 2, 2021

Two Weeks Away - Another SBIA | OTC Monograph Reform Webinar: OTC Sunscreen Drugs

Register today!

Receive this email as a forward? Subscribe to CDER SBIA industry updates.

CDER SBIA Webinar Registration

FDA | CDER | Small Business and Industry Assistance

WEBINARS

OTC Monograph Reform: OTC Sunscreen Drugs

December 15, 2021
3:00 PM - 4:00 PM ET


Register

ABOUT THIS WEBINAR

On September 24, 2021, FDA took steps aimed at improving the quality, safety, and efficacy of sunscreens as part of its implementation of new authorities for certain over-the-counter (OTC) drugs. FDA posted the deemed final order (DFO) for sunscreens which sets the current requirements for marketing OTC sunscreen products. FDA also posted the proposed order for sunscreens to amend and revise this deemed final order for OTC sunscreens products.

This webinar will:

  • Discuss the DFO for OTC sunscreen drugs and proposed order for OTC sunscreen drugs
  • Compare and contrast the major provisions of the DFO for OTC sunscreen drugs and the proposed order for OTC sunscreen drug

TOPICS

  • Overview of OTC sunscreen drugs
  • Relevant regulatory history for OTC sunscreen drugs
  • Overview of OTC Monograph Reform
  • DFO for OTC sunscreen drugs
  • Proposed Order for OTC sunscreen drugs

FDA SPEAKER

Steven Adah, PhD.
Associate Director of Monographs
Office of Nonprescription Drugs (ONPD) | CDER | FDA

 

AUDIENCE

  • General public with an interest in nonprescription (also known as over-the-counter or OTC) drugs
  • Regulatory affairs professionals involved in the development or marketing of OTC drugs
  • Foreign regulators following the development or marketing of OTC drugs
  • Consultants focused on OTC drug development or marketing
  • Clinical research coordinators
  • Importers of OTC drugs

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration · 
10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA
GovDelivery logo

No comments:

Post a Comment